The aim of the systematic review was to analyze the use of mesenchymal stem cells (MSC) and biomaterial for periodontal regeneration from preclinical animal models and human. Electronic databases were searched and additional hand-search in leading journals was performed. The research strategy was achieved according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The including criteria were as follows: MSC, biomaterial, in vivo studies, with histologic and radiologic analysis and written in English. The risk of bias was assessed for individual studies. A total of 50 articles were selected and investigated in the systematic review. These results indicate that MSC and scaffold provide beneficial effects on periodontal regeneration, with no adverse effects of such interventions. Future studies need to identify the suitable association of MSC and biomaterial and to characterize the type of new cementum and the organization of the periodontal ligament fiber regeneration.
INTRODUCTION
The periodontium is a highly specialized and dynamic tissue. It consists in a tooth-anchoring device made of two soft tissues, the gingiva and the periodontal ligament, and of two hard tissues, the cement and the alveolar bone. The gingiva, part of the superficial periodontium, is composed of an epithelium and a connective tissue, forming a periodontal attachment system that allows fluid exchange and assures a complete crimp around the tooth 1) . As for the deep periodontium, made of the periodontal ligament, the cement and the alveolar bone, it acts like an alveolar anchorage system, enabling both stability and damping of the tooth. In the oral environment, the periodontium is confronted with more than 1,000 bacteria species 2) . Thus, the space between the tooth and the surrounding gingiva, called sulcus, can become a gateway to potential inflammatory diseases. The most common cause of periodontal destruction is periodontitis 3, 4) . This multifactorial disease is due to an opportunistic bacteria contamination on a specific site, paired with local risk factors (e.g., insufficient oral hygiene, decay) and general risk factors (e.g., HIV, diabetes). In response to this bacterial aggression, an inflammatory process in the gingival sulcus will slowly destroy the periodontal structures and attachment, leading to tooth mobility and premature tooth loss 5) .
Conventional treatment strategies are based on a sustained decrease in the microbial load through a nonsurgical or a surgical elimination of the dental plaque associated with assiduous plaque control from the patient. In spite of great progress in the understanding of the pathogenesis of periodontitis, the tools to treat it seem to only postpone the unavoidable tooth loss linked to periodontal disease, and fail to restore ad integrum periodontal tissue, proving it unsatisfactory both for patients and for dental surgeons. Since the 1970s, several procedures have been attempted to restore such lost tissues, including autogenous bone grafting, implantation of biomaterials including bone derivatives and bone substitutes, guided-tissue regeneration (GTR) procedures 6) , and implantation of biologic factors, including enamel matrix proteins 7, 8) . Still, these strategies fail to regenerate the complete periodontium damage since the quality of repaired tissue remain variable and limited 9, 10) . To date, complete periodontal regeneration is not achievable in a highly reproducible and easy way. Therefore, functional and aesthetic sequelae are commonly found in treated patients with a history of periodontitis.
That is why, re-establishing the original structure, proprieties and functions of the diseased periodontium remains a significant clinical challenge. To address this issue, regenerative medicine using an effective combination of mesenchymal stem cells (MSC) and biomaterial have become subjects of particular interest 11) . Thus, a wide variety of the studies focus on MSC and try to combine their potential with suitable biomaterials in order to obtain a periodontal regeneration 12) . Despite numerous publications in pre-clinical animal models and humans, the efficacy of the association of MSC and biomaterial for periodontal regeneration remain controversial 13, 14) .
To increase the value of individual preclinical studies as proof of concept for randomized clinical trials, systematic reviews have been proposed as the 15) . Systematic review is an essential tool for summarizing evidence reliably and accurately. It provides a starting point for guideline developers for clinical practice. In the case of regenerative medicine for the enhancement of periodontal regeneration, a systematic review may provide valuable information for a suitable clinical practice. In this context, the purpose of the present systematic review was to assess the scientific literature to obtain more clarity on the efficacy of periodontal regeneration strategies using the association of MSC and biomaterials in pre-clinical animal and human studies.
Periodontal regenerative medicine using mesenchymal stem cells and biomaterials: A systematic review of pre-clinical studies

MATERIALS AND METHODS
The different studies concerning periodontal regeneration with the help of MSC and biomaterials on human or animal models have been collected and analyzed.
Study selection and inclusion/exclusion criteria
For the selection of studies, two investigators (SP, XS) screened the titles and the abstracts of the publications in an unblended, standardized manner. Selection was based on the inclusion and exclusion criteria defined so as to include only the most valuable articles (Table 1) . Studies deemed to meet the inclusion criteria and those with insufficient information to make a clear decision were selected. The second phase consisted of assessing the whole articles by the same investigators to determine the eligibility of the study. The selection process was recorded in detail to a PRISMA flow diagram ( Fig. 1 ). Any disagreements between the two investigators regarding inclusion of a study were resolved by discussion.
Data collection process and data items
The characteristics of the study were extracted independently by the same investigators and recorded. The data were compared for accuracy and any discrepancies were discussed and resolved by consensus.
Both reviewers extracted from the included studies the following data: (1) Cell type, passage number, differentiation, number per defect; (2) Biomaterial (+/−membrane); (3) Animal models: species, strain, sex, age, weight; (4) Number of defects per group; (5) Defect type, size, induced inflammation; (6) Treatment groups; (7) Observation period; (8) Qualification of newly formed tissues; (9) Results ( Table 2 ). If one of these data is not reported in the Table, it means that the information is not mentioned by the authors.
Risk of bias in individual studies
To ascertain the risk of bias in eligible articles, the same investigators in a blind manner evaluated their methodology either by SYRCLE's Risk of Bias tool for animal intervention studies 16) , or by Risk Of Bias in Nonrandomized Studies of Interventions (ROBINS-I) tool 17) modified for human non-randomized trials; or by the Cochrane Collaboration's tool for human randomized trials 18) . The case reports were excluded from the risk of bias analysis because of the absence of adapted methodology.
Regarding SYRCLE's Risk of Bias tool, the unit of analysis errors is assessed as a "high risk of bias" if the interventions to parts of the body within one participant (i.e., splits mouth: control and experimental side) was reported. In addition, many items remain as "unclear" due to the poor description of methodology. In order to complete the investigation, two items were added mentioned as follows: "mention of randomization" and "mention of binding".
Concerning the Cochrane Collaboration's and SYRCLE's Risk of Bias tool, we considered that there was no exclusion of animals when the number of animals reported in the method section equaled to the number mentioned in the results section. Disagreements between the investigators were resolved by consensus.
Data synthesis
A meta-analysis could not be performed because of the studies' heterogeneity. Consequently, we conducted a descriptive and systematic analysis of the studies.
RESULTS
Study selection
Taking into account the previously defined criteria, 1,423 studies were initially identified ( Fig. 1 Research and the Journal of Periodontology. After adjusting for duplicates and reading the title and/or the abstract, 96 studies remained. Out of these, 96 were discarded because after reviewing the whole article, it appeared that these papers clearly did not meet the inclusion criteria. A total of 50 articles were included in the systematic review.
Study characteristics
The studies were then ranked in a comparative Table  (Tables 2 and 3) according to the alphabetical order. These tables show a wide variety of combinations of MSC and biomaterials. The review began with an analysis of the type of population, mainly of preclinical animal species. Indeed, experimental models in majority are found in dogs, employed in 25 studies. Twelve studies were performed with miniature pigs and two with sheeps. Only 11 studies have been performed with humans. A variety of periodontal defects were used in the selected studies, including class III furcation defects (7 studies), fenestration defects (3 studies), intrabony with class II furcation defects (1 study), class II furcation defects (6 studies), dehiscence defects (2 studies), a root-shaped implant sockets (2 studies), alveolar sockets (2 studies), combined periodontal-endodontic lesions (1 study) but most of the articles used intrabony defects (26 studies). It seemed relevant to underline that although periodontitis is an inflammatory disease, the defects models employed in preclinical studies were largely not inflammatory (in 26/39 studies, defects were surgically created). Then, the studies were categorized according to the type of MSC or biomaterial used. The periodontal ligament stem cells (PDLSC) were by far the most studied with 16 publications, whereas bone marrow stem cells (BMSC) were used in only 12 studies. As for scaffolds, collagen is used in most of the studies (10 studies). The general analysis of clinical studies has shown that studies mostly based on animals mainly used a combination of PDLSC and collagen. Figure 2 shows the overall results of the risk of bias assessment. Subgroup analyses was performed to assess the quality of preclinical studies ( Fig. 2a) , non-randomized human trials ( Fig. 2b) and randomized human trials (Fig. 2c ), using an adapted methodology. Firstly, the risk of bias assessment for preclinical animal studies was investigated. Establishing that only 44 and 72% of the studies do not mention randomization or blinding respectively, our data show a high score of unclear risk of bias for the selection, performance and detection items (47, 95 and 95%, respectively) . Interestingly, the data outcomes were adequately addressed for 87% of the studies. Furthermore, the majority of the studies were free from selective outcome reporting (67%). Thereafter, non-randomized human trials were investigated for the quality of the methodology. Results revealed that 75 and 50% of the studies were marked for unclear risk of bias for pre-intervention and at-intervention items respectively. On the opposite, post-intervention items display a low risk of bias (88%). As expected for randomized human trials, our results did not show a high risk of bias. However, regarding selection bias, 33% of the included studies were marked for an unclear risk of bias. In addition, only 33% of the articles were considered to have a low risk of bias for its performance and detection. Finally, all studies were considered to have a low risk of bias for their attrition and reporting.
Risk of bias within studies
Synthesis of results
For each study, the relevant results are summarized for studies of preclinical animal models ( Table 2 ) and for Human studies (Table 3 ). Overall analysis showed the association of MSC and biomaterial enhancement of periodontal regeneration for the majority of the studies.
DISCUSSION
The significant impact of periodontal disease on general health and the quality of life necessitates the need to regenerate the damaged tissue more effectively 19) . Consequently, the regeneration of bone, cementum and an effective periodontal ligament remains a major challenge. Periodontal regenerative medicine is considered as a promising treatment modality for future therapy. Along this line, the present systematic review intended to investigate the controversial results raised from the scientific literature on the efficacy of the periodontal regeneration strategies, using the association of MSC and biomaterials in pre-clinical animal models and humans. Literature searches retrieved 50 studies. After a careful analysis, our results revealed that it was not possible to perform direct head-to-head comparisons of these studies as a result of variations between studies, in terms of the healing time after cell transplantation, the biomaterials applied, the defect type and size, the used cell types and passage number, and the number of cells per defect. Not surprisingly, no meta-analysis of the data could be carried out.
Indeed, the study of the risk of bias has revealed that poor reporting of animal studies in scientific publications is of serious concern. Preclinical animal studies and case reports are, in general, analyzed with less methodological rigour than trials. Key measures to avoid bias such as, randomization and blinding, were infrequently reported. This may lead to an overestimation of the effects of cells on periodontal regeneration compared to the group control system. This seriously hampers drawing reliable conclusions from animal studies. Despite these limitations, the combined analysis of the included studies still generated extra and valuable information that could not be derived from the individual analysis of studies.
Periodontal regenerative medicine is a multidisciplinary field combining biology and engineering. In this context, the present discussion focuses first on MSC and second on biomaterials used for periodontal regeneration. Stem cell biology has become an important field in regenerative medicine and tissue engineering therapy since the discovery and characterization of MSC. In particular, stem cells have great versatility at the level of tissue regeneration for many different characteristics and can modulate chronic inflammation, a central feature in periodontitis. Given the characteristics of these cells, they are considered a potentially useful tool for the efficient regeneration of periodontal tissues 20) . Thus, one of the most important issues for clinical application of regenerative medicine approaches is the type of cell used.
Bone marrow has been the main source of MSC used for regenerative medicine. For several years now, BMSC has been the object of a lot of periodontal regeneration research, more often on animal models. To date, there exists only one case reported on a human suffering from chronic periodontitis. The authors concluded that the combination of BMSC and Platelet-rich Plasm (PRP) should entail a radiological and clinical improvement in terms of pocket depth, attachment gain, loss of bleeding on probing, and tooth mobility 21) . In addition, a randomized trial, focusing on the safety and the efficacy of regenerative treatment of infrabony defects using autologous BMSC, combined with collagen scaffolds enriched with fibrin glue is ongoing (NIH clinical trial registration number: NCT02449005). The combination of BMSC and PRP has also been a success on animal models in 3 different studies, each independently conducted by Simsek et al., Hasegawa et al., . Even though the periodontal regeneration was nearly complete in the study by Simsek et al, both Hasegawa and Kawaguchi unfortunately concluded with incomplete tissue regeneration and particularly, that of the alveolar bone. With average positive results, the BMSC seems to enable an improvement in bone, periodontal ligament and cement regeneration 25, 26) . However, bone marrow suffers certain limitations that are related to its painful harvest and to the limited number of collectable cells. In light of these limitations, authors investigate other sources of adult tissues in order to collect stem cells. Within the orofacial area, several sources of MSC have attracted scientific interest, given their similarity to BMSC, their immunoregulatory capacity, and their minimally invasive harvest procedure 27) .
Periodontal (PDL) derived cells
Thirty years ago, the concept that stem cells may reside in the periodontal tissues was put forward by Melcher 28) . Not until 2004, PDLSC were first isolated and characterized as stem cells 29) . Over the past several years, the number of animal studies on PDL-derived cells have been increasing. Not surprisingly, in the present systematic review, the majority, i.e. 40% of the 50 studies were dedicated to periodontal ligamentderived cells. Feng et al. were the first to transplant progenitor cells of the periodontal ligament combined with calcium carbonate, into periodontal defects of 3 patients suffering from chronic periodontitis. The results concluded in a gain of clinical attachment with a decrease in pocket depth, a bone tissue regeneration and finally, a recession improvement over 72 months 30) . Menicanin et al. have combined autologous PDLSC to a gelatin scaffold on sheep models. The results in the test groups were very encouraging due to a superior regeneration with the development of cement, bone and ligament structures 31) . In addition, Liu et al. and Ding et al. independently obtained the same types of results, with a near complete regeneration of the periodontal tissues after implanting a combination of autologous PDLSC to HA/βTCP in intrabony defects on porcine models over a period of 12 weeks 32, 33) . Moreover, in order to simplify the clinical protocol set for the dental surgeon in his everyday practice, some studies use periodontal ligament cells without isolating the stem cells beforehand. Combined with either a collagen scaffold, calcium carbonate, PGA, HA, β-TCP or hyaluronic acid, different authors agree that their cells shown a significant improvement in terms of the height and thickness of the bone, of cement and the periodontal ligament regeneration 30, [34] [35] [36] [37] [38] [39] . A systematic review by Bright et al. on PDL-derived cells for periodontal regeneration reported that 12 out of the 17 included studies relate a statistically significant positive effect in periodontal regeneration 14) . A recent randomized clinical trial on 20 patients suffering from chronic periodontitis revealed that the implantation of PDLSC associated with Bio-Oss ® over a period of 1 year significantly improved the alveolar bone height and the clinical parameters over time, but no significant differences between the implantation of PDLSC/Bio-Oss ® and the implantation of only Bio-Oss ® were found 40) . In conclusion, even if the results are contradictory, the majority of the studies reveal a positive and promising effect on the regenerative potential of PDL-derived cells.
The use of dental pulp stem cells (DPSC) has shown some potential towards regenerating the periodontium. Interestingly, 3 independent case reports described an improvement of the clinical parameters of periodontitis by the implantation of DPSC with collagen scaffold 41, 42) or β-TCP 43) . Although the results of several pre-clinical animal studies and case reports were promising, human randomized trials are required to evaluate the efficacy of those procedures in regenerating true periodontal defects.
The others stem cells used
The efficiency of cellular therapy using autologous gingival fibroblasts has been evaluated by Fawzy et al. when they were combined with gingival margin stem cells (GMSC) to Bio-Oss ® or IL-1ra-releasing HA-ECM scaffold on a miniature pig subject. Whatever the biomaterial used, the team of researchers concluded with a reduction of pocket depth, a gain of clinical attachment and of bone density 44, 45) . In 2008, Yamamiya et al. conducted a study on 30 patients suffering from chronic periodontitis, where they combined periosteal cells with PRP and HA over a period of 1 year 46) . The results were positive from a clinical and a radiological point of view. Okuda et al. also studied the same combination in a dog model and reached the same conclusion 47) . Adipose stem cells (ASC) has always seemed very appealing to researchers in periodontal regeneration. Tobita et al. and Ozasa et al. implanted ACS into periodontal defects on canine models with PRP 48) or fibrin gel 49) , respectively. The morphometric, histologic, immuno-histologic and radiological analysis confirmed a superior bone, cement and ligament formation in the cell group.
Interestingly, a previous systematic review and meta-analysis, which included a large number of studies using only animal models (sheep, dog, minipigs, rats, mice), provided evidence for the enhancement of periodontal regeneration by the implantation of either PDL-derived cells or BMSC 50, 51) .
To have a chance of achieving periodontal regeneration, the cells need to be delivered and stabilized on the defect by a biomaterial. The concept of a scaffold is based on a biomimetic strategy, capable of incorporating and releasing molecules, and permitting cell to cell and cell to matrix interactions. The choice of the releasing method will depend on the type of cell population released and on the type of defect; specifically, the number of alveolar bone walls involved. When defects are larger, outcomes may improve when cells are associated with bone substitute or cell sheets attached with PGA are transplanted onto the tooth root surface, after which the bone defects are filled with bone substitute 36, 38, 39, 52, 53) . On the opposite, gel scaffold might be used when lesions are retentive. As shown in this systematic review, clinical studies mainly use a scaffold made of collagen. Collagen materials may be particularly useful due to their biocompatibility, resorbability, cell occlusiveness and their capability of promoting wound healing. Collagen offer a safe scaffold material because of occurring naturally and being involved in numerous physiological processes. Although collagen can be constituted into various forms such as fibers, sheets, hydrogels, and sponges 11) . Most biomaterials have some drawbacks such as follows: unpredictable cell-biomaterial interactions, non-homogeneous biodegradation, immune reaction, and low efficiency cell seeding. Injectable scaffolds, easily applied without invasive surgery, can improve cell retention, distribution and more importantly activate in situ cell proliferation and differentiation. Hydrogels are not only biocompatible with a high resorption level but they show a better cell retention than other injectable biomaterials, as confirmed by a number of studies 54) . They can be prepared from alginate, chitosan, collagen or cellulose, seeded with cells and then gelation can be initiated by changing the temperature, pH, cross-linking or radical polymerization. The goal is to obtain a high cell retention followed by a good integration capacity and a high level of surviving cells with reduced side effects and minimal stress for the patient 12) .
The present systematic review achieves, for the first time, a comprehensive analysis of the scientific literature concerning the periodontal regenerative medicine. To date, current data indicate that MSC associated with suitable scaffolds may provide beneficial effects on periodontal regeneration in preclinical animal models and humans. In particular interest, the human studies suggest that there are no adverse effects of such interventions 40, 42) .
Although clinical trials are promising, future animal studies are still needed to determine the suitable association of MSC and biomaterial for periodontal regeneration and to characterize the type of cementum, and the organization of the periodontal ligament fiber that is regenerated. Furthermore, these studies should also compare periodontal regenerative medicine with the gold standard therapies used to repair periodontium.
CONCLUSION
Several approaches using MSC for regenerating damaged periodontium are under study with varying degrees of clinical applications. Given the heterogeneity of the studies concerning the periodontal regenerative medicine, narrative reviews are insufficient. A systematic approach appears essential to provide guidance to support future studies and should provide information that can be generalized. Our results indicate that MSC may provide beneficial effects on periodontal regeneration. The present systematic review supports crucial information for the implementation of regenerative medicine strategies in clinical practice in the future.
